| 名称 | Pucotenlimab |
| 描述 | Pucotenlimab (HX008) is a humanized IgG4 monoclonal antibody that specifically targets the programmed cell death protein 1 (PD-1) immune checkpoint. it potently blocks the interaction of PD-1 with its ligands, PD-L1 and PD-L2, thereby restoring the ability of immune cells to target and eliminate cancer cells, Pucotenlimab can be used in studies about a wide range of solid tumours. |
| 存储条件 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 相关产品 | BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride | BMS202 hydrochloride (1675203-84-5(free base)) | Sulfamethoxypyridazine | PD-L1-IN-3 | Tomivosertib | LSD1-IN-27 | Nivolumab | LSD1-IN-24 | IMMH 010 maleate | PD-1/PD-L1-IN-9 | Fraxinellone | PD-1-IN-22 |
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的，不可用于人类或动物的临床诊断、治疗或实验，不可药用，不可食用。
Copyright© 2022-2026 上海捷世凯生物科技有限公司 版权所有，All Rights Reserved 沪ICP备2022023965号
沪公网安备 31012002005937 
许可证编号：沪（奉）应急管危经许[2025]203724
主管 朱如燕 13795461237
售后 全香 15901740225
微信公众号
